QIAGEN N.V. (QIAGEN) is a provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. The Company has developed a portfolio of more than 500 consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification, as well as open and target specific assays. The Company also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. Products are sold to academic research markets, to pharmaceutical and biotechnology companies, to applied testing customers (such as in forensics, veterinary, biodefense and industrial applications), as well as to molecular diagnostics laboratories. In addition, the Company sells and/or licenses technologies to others. The Company’s products are markets in more than 40 countries. In January 2010, the Company announced that it has acquired ESE GmbH.